BRUKER CORPORATION Increase (Decrease) in Accounts Payable and Accrued Liabilities
BRUKER CORPORATION (BRKR) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$80.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-05
- BRUKER CORPORATION increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-06-30 was -$91.20M.
- BRUKER CORPORATION increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2026-03-31 was $11.20M, a 57.58% decline year-over-year.
- BRUKER CORPORATION increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was -$56.90M, a 372.25% decline year-over-year.
- BRUKER CORPORATION increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-06-30 was -$62.40M, a 770.97% decline year-over-year.
- BRUKER CORPORATION increase (decrease) in accounts payable and accrued liabilities for fiscal 2023 was $23.10M, a 75.00% increase from fiscal 2022.
- BRUKER CORPORATION increase (decrease) in accounts payable and accrued liabilities for fiscal 2022 was $13.20M, a 78.50% decline from fiscal 2021.
- BRUKER CORPORATION increase (decrease) in accounts payable and accrued liabilities for fiscal 2021 was $61.40M.
- BRUKER CORPORATION increase (decrease) in accounts payable and accrued liabilities for fiscal 2020 was -$2.40M, a 115.09% decline from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$91.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$80.00M 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $11.20M 10-Q · filed 2026-05-07 | |||
| 2025-09-30 | -$56.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$119.30M derived: sum of 2 quarters · filed 2026-08-05 | -$92.90M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | -$62.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$36.00M 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | $26.40M 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | $20.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $30.20M derived: sum of 2 quarters · filed 2025-11-05 | $26.50M 10-Q · filed 2025-11-05 | $38.50M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $5.60M 10-Q · filed 2024-08-09 | $17.60M derived: sum of 3 quarters · filed 2024-08-09 | $32.10M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | -$3.70M 10-Q · filed 2024-05-10 | $8.30M derived: sum of 2 quarters · filed 2024-05-10 | $22.80M derived: sum of 3 quarters · filed 2024-11-07 | $6.30M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $26.50M derived: sum of 2 quarters · filed 2024-11-07 | $10.00M derived: sum of 3 quarters · filed 2024-11-07 | $23.10M 10-K · filed 2024-02-29 |
| 2023-09-30 | $14.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.00M derived: sum of 2 quarters · filed 2024-11-07 | $11.10M 10-Q · filed 2024-11-07 | $24.00M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$16.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$3.40M 10-Q · filed 2024-08-09 | $9.50M derived: sum of 3 quarters · filed 2024-08-09 | $27.10M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $13.10M 10-Q · filed 2024-05-10 | $26.00M derived: sum of 2 quarters · filed 2024-05-10 | $43.60M derived: sum of 3 quarters · filed 2024-05-10 | $26.40M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $30.50M derived: sum of 2 quarters · filed 2024-02-29 | $13.30M derived: sum of 3 quarters · filed 2024-02-29 | $13.20M 10-K · filed 2024-02-29 |
| 2022-09-30 | $17.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $400.00K derived: sum of 2 quarters · filed 2023-11-09 | $300.00K 10-Q · filed 2023-11-09 | $15.80M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$17.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$17.30M 10-Q · filed 2023-08-09 | -$1.80M derived: sum of 3 quarters · filed 2024-02-29 | $31.10M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$100.00K 10-Q · filed 2023-05-10 | $15.40M derived: sum of 2 quarters · filed 2024-02-29 | $48.30M derived: sum of 3 quarters · filed 2024-02-29 | $25.80M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $48.40M derived: sum of 2 quarters · filed 2024-02-29 | $25.90M derived: sum of 3 quarters · filed 2024-02-29 | $61.40M 10-K · filed 2024-02-29 |
| 2021-09-30 | $32.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $10.40M derived: sum of 2 quarters · filed 2022-11-04 | $45.90M 10-Q · filed 2022-11-04 | $58.80M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$22.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $13.00M 10-Q · filed 2022-08-05 | $25.90M derived: sum of 3 quarters · filed 2023-03-01 | $26.70M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $35.50M 10-Q · filed 2022-05-06 | $48.40M derived: sum of 2 quarters · filed 2023-03-01 | $49.20M derived: sum of 3 quarters · filed 2023-03-01 | $14.00M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $12.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $13.70M derived: sum of 2 quarters · filed 2023-03-01 | -$21.50M derived: sum of 3 quarters · filed 2023-03-01 | -$2.40M 10-K · filed 2023-03-01 |
| 2020-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | -$34.40M derived: sum of 2 quarters · filed 2021-11-05 | -$15.30M 10-Q · filed 2021-11-05 | -$9.70M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$35.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$16.10M 10-Q · filed 2021-08-05 | -$10.50M derived: sum of 3 quarters · filed 2022-02-28 | -$3.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $19.10M 10-Q · filed 2021-05-10 | $24.70M derived: sum of 2 quarters · filed 2022-02-28 | $32.20M derived: sum of 3 quarters · filed 2022-02-28 | $24.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $13.10M derived: sum of 2 quarters · filed 2022-02-28 | $4.90M derived: sum of 3 quarters · filed 2022-02-28 | $15.90M 10-K · filed 2022-02-28 |
| 2019-09-30 | $7.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$700.00K derived: sum of 2 quarters · filed 2020-11-06 | $10.30M 10-Q · filed 2020-11-06 | $16.50M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$8.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.80M 10-Q · filed 2020-08-07 | $9.00M derived: sum of 3 quarters · filed 2021-03-01 | $21.40M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $11.00M 10-Q · filed 2020-05-11 | $17.20M derived: sum of 2 quarters · filed 2021-03-01 | $29.60M derived: sum of 3 quarters · filed 2021-03-01 | $29.70M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $18.60M derived: sum of 2 quarters · filed 2021-03-01 | $18.70M derived: sum of 3 quarters · filed 2021-03-01 | $5.00M 10-K · filed 2021-03-01 |
| 2018-09-30 | $12.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $12.50M derived: sum of 2 quarters · filed 2019-11-04 | -$1.20M 10-Q · filed 2019-11-04 | $41.10M derived: sum of 4 quarters · filed 2020-03-27 |
| 2018-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$13.60M 10-Q · filed 2019-08-09 | $28.70M derived: sum of 3 quarters · filed 2020-03-27 | $44.50M derived: sum of 4 quarters · filed 2020-03-27 |
| 2018-03-31 | -$13.70M 10-Q · filed 2019-05-08 | $28.60M derived: sum of 2 quarters · filed 2020-03-27 | $44.40M derived: sum of 3 quarters · filed 2020-03-27 | $22.70M derived: sum of 4 quarters · filed 2020-03-27 |
| 2017-12-31 | $42.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $58.10M derived: sum of 2 quarters · filed 2020-03-27 | $36.40M derived: sum of 3 quarters · filed 2020-03-27 | $33.70M 10-K · filed 2020-03-27 |
| 2017-09-30 | $15.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$5.90M derived: sum of 2 quarters · filed 2018-11-09 | -$8.60M 10-Q · filed 2018-11-09 | -$16.70M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$21.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$24.40M 10-Q · filed 2018-08-09 | -$32.50M derived: sum of 3 quarters · filed 2019-03-01 | -$31.70M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$2.70M 10-Q · filed 2018-05-10 | -$10.80M derived: sum of 2 quarters · filed 2019-03-01 | -$10.00M derived: sum of 3 quarters · filed 2019-03-01 | -$13.30M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$8.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$7.30M derived: sum of 2 quarters · filed 2019-03-01 | -$10.60M derived: sum of 3 quarters · filed 2019-03-01 | -$19.60M 10-K · filed 2019-03-01 |
| 2016-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$2.50M derived: sum of 2 quarters · filed 2017-11-09 | -$11.50M 10-Q · filed 2017-11-09 | -$3.70M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | -$3.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$12.30M 10-Q · filed 2017-08-09 | -$4.50M derived: sum of 3 quarters · filed 2018-03-16 | $7.60M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | -$9.00M 10-Q · filed 2017-05-10 | -$1.20M derived: sum of 2 quarters · filed 2018-03-16 | $10.90M derived: sum of 3 quarters · filed 2018-03-16 | $10.40M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | $7.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $19.90M derived: sum of 2 quarters · filed 2018-03-16 | $19.40M derived: sum of 3 quarters · filed 2018-03-16 | $12.60M 10-K · filed 2018-03-16 |
| 2015-09-30 | $12.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $11.60M derived: sum of 2 quarters · filed 2016-11-09 | $4.80M 10-Q · filed 2016-11-09 | -$10.90M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | -$7.30M 10-Q · filed 2016-08-05 | -$23.00M derived: sum of 3 quarters · filed 2017-03-01 | -$7.20M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$6.80M 10-Q · filed 2016-05-06 | -$22.50M derived: sum of 2 quarters · filed 2017-03-01 | -$6.70M derived: sum of 3 quarters · filed 2017-03-01 | -$19.70M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$15.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $100.00K derived: sum of 2 quarters · filed 2017-03-01 | -$12.90M derived: sum of 3 quarters · filed 2017-03-01 | $9.00M 10-K · filed 2017-03-01 |
| 2014-09-30 | $15.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $2.80M derived: sum of 2 quarters · filed 2015-11-06 | $24.70M 10-Q · filed 2015-11-06 | $26.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | -$13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $8.90M 10-Q · filed 2015-08-07 | $10.20M derived: sum of 3 quarters · filed 2016-02-29 | $30.00M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $21.90M 10-Q · filed 2015-05-08 | $23.20M derived: sum of 2 quarters · filed 2016-02-29 | $43.00M derived: sum of 3 quarters · filed 2016-02-29 | $36.70M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $21.10M derived: sum of 2 quarters · filed 2016-02-29 | $14.80M derived: sum of 3 quarters · filed 2016-02-29 | $7.00M 10-K · filed 2016-02-29 |
| 2013-09-30 | $19.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $13.50M derived: sum of 2 quarters · filed 2014-11-07 | $5.70M 10-Q · filed 2014-11-07 | $21.30M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-06-30 | -$6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$14.10M 10-Q · filed 2014-08-08 | $1.50M derived: sum of 3 quarters · filed 2015-02-27 | -$5.20M derived: sum of 4 quarters · filed 2015-02-27 |
| 2013-03-31 | -$7.80M 10-Q · filed 2014-05-09 | $7.80M derived: sum of 2 quarters · filed 2015-02-27 | $1.10M derived: sum of 3 quarters · filed 2015-02-27 | $5.60M derived: sum of 4 quarters · filed 2015-02-27 |
| 2012-12-31 | $15.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $8.90M derived: sum of 2 quarters · filed 2015-02-27 | $13.40M derived: sum of 3 quarters · filed 2015-02-27 | $4.60M 10-K · filed 2015-02-27 |
| 2012-09-30 | -$6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$2.20M derived: sum of 2 quarters · filed 2013-11-08 | -$11.00M 10-Q · filed 2013-11-08 | -$5.90M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$4.30M 10-Q · filed 2013-08-08 | $800.00K derived: sum of 3 quarters · filed 2014-02-27 | |
| 2012-03-31 | -$8.80M 10-Q · filed 2013-05-09 | -$3.70M derived: sum of 2 quarters · filed 2014-02-27 | ||
| 2011-12-31 | $5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $23.40M 10-K · filed 2014-02-27 | ||
| 2011-09-30 | $18.30M 10-Q · filed 2012-11-08 | |||
| 2010-12-31 | $29.60M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |